vs
RIGEL PHARMACEUTICALS INC（RIGL）与RE/MAX Holdings, Inc.（RMAX）财务数据对比。点击上方公司名可切换其他公司
RE/MAX Holdings, Inc.的季度营收约是RIGEL PHARMACEUTICALS INC的1.0倍（$71.1M vs $69.8M），RIGEL PHARMACEUTICALS INC净利率更高（384.0% vs 2.0%，领先382.0%），RIGEL PHARMACEUTICALS INC同比增速更快（21.2% vs -1.8%），过去两年RIGEL PHARMACEUTICALS INC的营收复合增速更高（53.7% vs -4.7%）
Rigel制药是一家临床阶段生物技术企业，专注于研发及商业化针对自身免疫性疾病、炎症性疾病与血液疾病的靶向小分子疗法，核心市场位于美国，旗下已获批产品可治疗成人免疫性血小板减少症，致力于满足未被覆盖的临床医疗需求。
RE/MAX是全球知名的房地产特许经营机构，业务遍布全球一百多个国家和地区，旗下拥有数千家门店，总计超过十万名房产经纪人，在国际房产中介领域拥有极高的品牌知名度与市场影响力。
RIGL vs RMAX — 直观对比
营收规模更大
RMAX
是对方的1.0倍
$69.8M
营收增速更快
RIGL
高出23.0%
-1.8%
净利率更高
RIGL
高出382.0%
2.0%
两年增速更快
RIGL
近两年复合增速
-4.7%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $69.8M | $71.1M |
| 净利润 | $268.1M | $1.4M |
| 毛利率 | 91.5% | — |
| 营业利润率 | 33.2% | 13.1% |
| 净利率 | 384.0% | 2.0% |
| 营收同比 | 21.2% | -1.8% |
| 净利润同比 | 1769.2% | -75.2% |
| 每股收益（稀释后） | $14.11 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收RIGLRMAX
| Q4 25 | $69.8M | $71.1M | ||
| Q3 25 | $69.5M | $73.2M | ||
| Q2 25 | $101.7M | $72.8M | ||
| Q1 25 | $53.3M | $74.5M | ||
| Q4 24 | $57.6M | $72.5M | ||
| Q3 24 | $55.3M | $78.5M | ||
| Q2 24 | $36.8M | $78.5M | ||
| Q1 24 | $29.5M | $78.3M |
净利润RIGLRMAX
| Q4 25 | $268.1M | $1.4M | ||
| Q3 25 | $27.9M | $4.0M | ||
| Q2 25 | $59.6M | $4.7M | ||
| Q1 25 | $11.4M | $-2.0M | ||
| Q4 24 | $14.3M | $5.8M | ||
| Q3 24 | $12.4M | $966.0K | ||
| Q2 24 | $-1.0M | $3.7M | ||
| Q1 24 | $-8.2M | $-3.4M |
毛利率RIGLRMAX
| Q4 25 | 91.5% | — | ||
| Q3 25 | 93.2% | — | ||
| Q2 25 | 95.6% | — | ||
| Q1 25 | 91.7% | — | ||
| Q4 24 | 89.9% | — | ||
| Q3 24 | 85.5% | — | ||
| Q2 24 | 92.4% | — | ||
| Q1 24 | 93.1% | — |
营业利润率RIGLRMAX
| Q4 25 | 33.2% | 13.1% | ||
| Q3 25 | 40.9% | 25.0% | ||
| Q2 25 | 60.1% | 19.3% | ||
| Q1 25 | 23.9% | 7.2% | ||
| Q4 24 | 28.9% | 5.9% | ||
| Q3 24 | 25.4% | 19.4% | ||
| Q2 24 | 1.2% | 20.6% | ||
| Q1 24 | -23.6% | 5.8% |
净利率RIGLRMAX
| Q4 25 | 384.0% | 2.0% | ||
| Q3 25 | 40.2% | 5.4% | ||
| Q2 25 | 58.6% | 6.4% | ||
| Q1 25 | 21.5% | -2.6% | ||
| Q4 24 | 24.9% | 8.0% | ||
| Q3 24 | 22.5% | 1.2% | ||
| Q2 24 | -2.8% | 4.7% | ||
| Q1 24 | -27.9% | -4.3% |
每股收益（稀释后）RIGLRMAX
| Q4 25 | $14.11 | — | ||
| Q3 25 | $1.46 | — | ||
| Q2 25 | $3.28 | — | ||
| Q1 25 | $0.63 | — | ||
| Q4 24 | $0.82 | — | ||
| Q3 24 | $0.70 | — | ||
| Q2 24 | $-0.06 | — | ||
| Q1 24 | $-0.47 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $155.0M | $118.7M |
| 总债务越低越好 | $52.5M | $432.2M |
| 股东权益账面价值 | $391.5M | $452.4M |
| 总资产 | $513.6M | $582.5M |
| 负债/权益比越低杠杆越低 | 0.13× | 0.96× |
8季度趋势，按日历期对齐
现金及短期投资RIGLRMAX
| Q4 25 | $155.0M | $118.7M | ||
| Q3 25 | $137.1M | $107.5M | ||
| Q2 25 | $108.4M | $94.3M | ||
| Q1 25 | $77.1M | $89.1M | ||
| Q4 24 | $77.3M | $96.6M | ||
| Q3 24 | $61.1M | $83.8M | ||
| Q2 24 | $49.1M | $66.1M | ||
| Q1 24 | $49.5M | $82.1M |
总债务RIGLRMAX
| Q4 25 | $52.5M | $432.2M | ||
| Q3 25 | $60.0M | $433.3M | ||
| Q2 25 | $60.0M | $434.4M | ||
| Q1 25 | $60.0M | $435.3M | ||
| Q4 24 | $60.0M | $436.2M | ||
| Q3 24 | $60.0M | $437.2M | ||
| Q2 24 | $60.0M | $438.1M | ||
| Q1 24 | $60.0M | $439.0M |
股东权益RIGLRMAX
| Q4 25 | $391.5M | $452.4M | ||
| Q3 25 | $117.6M | $448.1M | ||
| Q2 25 | $81.9M | $442.4M | ||
| Q1 25 | $18.6M | $433.5M | ||
| Q4 24 | $3.3M | $429.5M | ||
| Q3 24 | $-14.6M | $423.1M | ||
| Q2 24 | $-29.9M | $418.4M | ||
| Q1 24 | $-31.7M | $412.0M |
总资产RIGLRMAX
| Q4 25 | $513.6M | $582.5M | ||
| Q3 25 | $242.5M | $582.2M | ||
| Q2 25 | $206.7M | $574.8M | ||
| Q1 25 | $176.0M | $571.4M | ||
| Q4 24 | $164.0M | $581.6M | ||
| Q3 24 | $139.4M | $578.6M | ||
| Q2 24 | $128.4M | $571.4M | ||
| Q1 24 | $126.5M | $566.7M |
负债/权益比RIGLRMAX
| Q4 25 | 0.13× | 0.96× | ||
| Q3 25 | 0.51× | 0.97× | ||
| Q2 25 | 0.73× | 0.98× | ||
| Q1 25 | 3.23× | 1.00× | ||
| Q4 24 | 18.25× | 1.02× | ||
| Q3 24 | — | 1.03× | ||
| Q2 24 | — | 1.05× | ||
| Q1 24 | — | 1.07× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $22.0M | $40.9M |
| 自由现金流经营现金流 - 资本支出 | — | $33.5M |
| 自由现金流率自由现金流/营收 | — | 47.1% |
| 资本支出强度资本支出/营收 | — | 10.4% |
| 现金转化率经营现金流/净利润 | 0.08× | 28.39× |
| 过去12个月自由现金流最近4个季度 | — | $56.8M |
8季度趋势，按日历期对齐
经营现金流RIGLRMAX
| Q4 25 | $22.0M | $40.9M | ||
| Q3 25 | $24.0M | $17.7M | ||
| Q2 25 | $30.5M | $4.6M | ||
| Q1 25 | $-893.0K | $5.7M | ||
| Q4 24 | $14.5M | $59.7M | ||
| Q3 24 | $21.7M | $17.6M | ||
| Q2 24 | $302.0K | $15.9M | ||
| Q1 24 | $-5.0M | $9.4M |
自由现金流RIGLRMAX
| Q4 25 | — | $33.5M | ||
| Q3 25 | — | $16.4M | ||
| Q2 25 | — | $2.9M | ||
| Q1 25 | — | $4.0M | ||
| Q4 24 | — | $53.0M | ||
| Q3 24 | — | $16.3M | ||
| Q2 24 | — | $14.0M | ||
| Q1 24 | — | $6.8M |
自由现金流率RIGLRMAX
| Q4 25 | — | 47.1% | ||
| Q3 25 | — | 22.4% | ||
| Q2 25 | — | 4.0% | ||
| Q1 25 | — | 5.3% | ||
| Q4 24 | — | 73.2% | ||
| Q3 24 | — | 20.8% | ||
| Q2 24 | — | 17.8% | ||
| Q1 24 | — | 8.6% |
资本支出强度RIGLRMAX
| Q4 25 | — | 10.4% | ||
| Q3 25 | — | 1.8% | ||
| Q2 25 | — | 2.2% | ||
| Q1 25 | — | 2.3% | ||
| Q4 24 | — | 9.1% | ||
| Q3 24 | — | 1.7% | ||
| Q2 24 | — | 2.4% | ||
| Q1 24 | — | 3.3% |
现金转化率RIGLRMAX
| Q4 25 | 0.08× | 28.39× | ||
| Q3 25 | 0.86× | 4.45× | ||
| Q2 25 | 0.51× | 0.97× | ||
| Q1 25 | -0.08× | — | ||
| Q4 24 | 1.01× | 10.28× | ||
| Q3 24 | 1.75× | 18.22× | ||
| Q2 24 | — | 4.29× | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
RIGL
暂无分部数据
RMAX
| Franchising Segment | $50.1M | 70% |
| Broker Fees | $13.9M | 20% |
| Annual Dues | $7.4M | 10% |
